AUM’s value driven drug development process for innovative cancer therapeutics, is a culmination of several decades of research in the treatment of Asia-prevalent cancers. With a singular goal of making cancer treatment accessible and affordable to all, AUM is led by a team of clinicians and medical researchers with global & diverse, clinical and commercial experience of 100+ years. Every stakeholder is passionate about what they do, with an emphasis on democratising cancer management and treatment.
Management Team:
Vishal Doshi, Chairman of Board,
Chief Executive Officer